Alternatives to Prism AI

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

AI-driven platform for protein-level disease mapping and drug discovery.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Drug discovery and development company using a novel technological approach.

Leveraging AI and novel technology to extract deep health insights from routine blood tests.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Develops a platform for adaptive clinical trial design and closed-loop execution.

AI-powered blood test for early cancer detection and subtyping.

Computational biology platform for optimizing IVF success rates and reducing treatment burdens.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

EU-based company providing personalized medicine solutions for medical practitioners.